166 related articles for article (PubMed ID: 36870388)
1. Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Chakraborty R; Yi J; Rybicki L; Preussler J; Deol A; Loren A; Savani B; Jim HSL; Cerny J; Reynolds J; Whitten J; Wingard JR; McGuirk JP; Uberti J; Khera N; Stiff P; Jaglowski SM; Hashmi S; Holtan SG; Devine S; Hahn T; Whalen VL; Saber W; Wood W; Baker KS; Syrjala K; Majhail NS
Transplant Cell Ther; 2023 Jun; 29(6):388.e1-388.e6. PubMed ID: 36870388
[TBL] [Abstract][Full Text] [Related]
2. Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation.
Rotz SJ; Yi JC; Hamilton BK; Wei W; Preussler JM; Cerny J; Deol A; Jim H; Khera N; Hahn T; Hashmi SK; Holtan S; Jaglowski SM; Loren AW; McGuirk J; Reynolds J; Saber W; Savani BN; Stiff P; Uberti J; Wingard JR; Wood WA; Baker KS; Majhail NS; Syrjala KL
Transplant Cell Ther; 2022 Oct; 28(10):701.e1-701.e7. PubMed ID: 35872304
[TBL] [Abstract][Full Text] [Related]
3. Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.
Hong S; Zhao J; Wang S; Wang H; Lee JH; Farhadfar N; McGuirk JP; Savani BN; Shahrukh HK; Stiff P; Khera N; Hahn T; Loren AW; Jaglowski SM; Wood WA; Saber W; Cerny J; Holtan SG; Reynolds JM; Deol A; Jim H; Uberti J; Whalen V; Yi JC; Preussler J; Baker KS; Shaw BE; Devine S; Syrjala K; Majhail NS; Wingard JR; Al-Mansour Z
Transplant Cell Ther; 2023 Mar; 29(3):202.e1-202.e8. PubMed ID: 36427784
[TBL] [Abstract][Full Text] [Related]
4. Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors.
Farhadfar N; Weaver MT; Al-Mansour Z; Yi JC; Jim HSL; Loren AW; Majhail NS; Whalen V; Uberti J; Wingard JR; Lynch Kelly D; Syrjala KL
Transplant Cell Ther; 2022 Sep; 28(9):606.e1-606.e8. PubMed ID: 35662590
[TBL] [Abstract][Full Text] [Related]
5. Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.
Georges GE; Bar M; Onstad L; Yi JC; Shadman M; Flowers ME; Carpenter PA; Stewart S; Lee SJ; Holmberg LA
Biol Blood Marrow Transplant; 2020 Feb; 26(2):407-412. PubMed ID: 31605822
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.
Majhail NS; Murphy E; Laud P; Preussler JM; Denzen EM; Abetti B; Adams A; Besser R; Burns LJ; Cerny J; Drexler R; Hahn T; Idossa L; Jahagirdar B; Kamani N; Loren A; Mattila D; McGuirk J; Moore H; Reynolds J; Saber W; Salazar L; Schatz B; Stiff P; Wingard JR; Syrjala KL; Baker KS
Haematologica; 2019 May; 104(5):1084-1092. PubMed ID: 30514795
[TBL] [Abstract][Full Text] [Related]
7. Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
D'Souza A; Brazauskas R; Stadtmauer EA; Pasquini MC; Hari P; Bashey A; Callander N; Devine S; Efebera Y; Ganguly S; Gasparetto C; Geller N; Horowitz MM; Koreth J; Landau H; Brunstein C; McCarthy P; Qazilbash MH; Giralt S; Krishnan A; Flynn KE
Am J Hematol; 2023 Jan; 98(1):140-147. PubMed ID: 35567778
[TBL] [Abstract][Full Text] [Related]
8. Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.
Ullrich CK; Baker KK; Carpenter PA; Flowers ME; Gooley T; Stevens S; Krakow EF; Oshima MU; Salit RB; Vo P; Connelly-Smith L; Lee SJ; Wood WA
Transplant Cell Ther; 2023 Mar; 29(3):200.e1-200.e8. PubMed ID: 36494015
[TBL] [Abstract][Full Text] [Related]
9. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
[TBL] [Abstract][Full Text] [Related]
11. Telehealth exercise to Improve Physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic Stem cell transplantation (TIPS): protocol of a randomized controlled trial.
Lee K; Nathwani N; Shamunee J; Lindenfeld L; Wong FL; Krishnan A; Armenian S
Trials; 2022 Nov; 23(1):921. PubMed ID: 36329525
[TBL] [Abstract][Full Text] [Related]
12. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life.
Boland E; Eiser C; Ezaydi Y; Greenfield DM; Ahmedzai SH; Snowden JA
J Pain Symptom Manage; 2013 Nov; 46(5):671-80. PubMed ID: 23535325
[TBL] [Abstract][Full Text] [Related]
13. Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.
Auner HW; Garderet L; Kröger N
Br J Haematol; 2015 Nov; 171(4):453-62. PubMed ID: 26213240
[TBL] [Abstract][Full Text] [Related]
14. Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors.
Nørskov KH; Yi JC; Crouch ML; Fiscalini AS; Flowers MED; Syrjala KL
J Cancer Surviv; 2021 Dec; 15(6):866-875. PubMed ID: 33420905
[TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life after Autologous Stem Cell Transplantation for Multiple Myeloma.
Chakraborty R; Hamilton BK; Hashmi SK; Kumar SK; Majhail NS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1546-1553. PubMed ID: 29626515
[TBL] [Abstract][Full Text] [Related]
16. Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival.
Merz AMA; Merz M; Zhang Y; Stecklein K; Pleskow J; Chen GL; Buck DA; Mohammadpour H; Herr MM; Elshoury A; Hillengass J; McCarthy PL; Hahn T
Transplant Cell Ther; 2021 Mar; 27(3):245.e1-245.e8. PubMed ID: 34706824
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Hong S; Rybicki L; Abounader D; Bolwell BJ; Dean R; Gerds AT; Hamilton BK; Hill BT; Jagadeesh D; Kalaycio M; Liu HD; Pohlman B; Sobecks R; Majhail NS
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1141-1144. PubMed ID: 26995694
[TBL] [Abstract][Full Text] [Related]
19. Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma.
Costa LJ; Huang JX; Hari PN
Biol Blood Marrow Transplant; 2015 Apr; 21(4):701-6. PubMed ID: 25555447
[TBL] [Abstract][Full Text] [Related]
20. Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.
Stadtmauer EA; Pasquini MC; Blackwell B; Hari P; Bashey A; Devine S; Efebera Y; Ganguly S; Gasparetto C; Geller N; Horowitz MM; Koreth J; Knust K; Landau H; Brunstein C; McCarthy P; Nelson C; Qazilbash MH; Shah N; Vesole DH; Vij R; Vogl DT; Giralt S; Somlo G; Krishnan A
J Clin Oncol; 2019 Mar; 37(7):589-597. PubMed ID: 30653422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
